Guest Professor: Nikhil Dhurandhar, PhD
As a physician and nutritional biochemist, Dr. Dhurandhar has been involved with obesity treatment and research for over 20 years and has treated over 10,000 patients for obesity using lifestyle therapy as well as pharmacological approaches. He believes that simple explanations for causes of obesity are inadequate and novel approaches are required for its effective management. He coined the term “Infectobesity” to describe obesity of infectious origin. Dr. Dhurandhar et al were the first to identify adipogenic effects of an avian adenovirus (SMAM-1) and a human adenovirus (Ad36) that cause obesity in animals including rodents and monkeys, and are associated with obesity in humans and non-human primates. In a recent series of studies, Dr. Dhurandhar et al identified a novel adenoviral protein that could be exploited for its anti-diabetic properties. The long term objectives of his work include the development of a vaccine to prevent Ad36-induced obesity, and the development of anti-diabetic drugs based on the template provided by the viral protein. Dr. Dhurandhar has received research funding from the NIH, American Diabetes Association, Federal Emergency Management Agency, and other non-profit or commercial funding sources, has published over 100 scientific articles, and book chapters, and served as a mentor or advisor for several students and postdoctoral fellows.
This networking event is an opportunity to participate in a Q&A with an industry-leading professor. A limited number of seats are available on a first-come, first-serve basis through the registration site.
Sponsored by the Clinical Management of Obesity Section.